8
Participants
Start Date
March 8, 2023
Primary Completion Date
August 31, 2024
Study Completion Date
August 31, 2024
RD13-02 cell infusion
CAR-T cells
Affiliated hospital of Xuzhou medical college, Xuzhou
Nanjing Bioheng Biotech Co., Ltd.
INDUSTRY
Kai Lin Xu,MD
OTHER